Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study
IRC002 Study Team
Medicine
Pathology
Research output
:
Contribution to journal
›
Article
›
peer-review
89
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Human Influenza
100%
Standard of Care
23%
National Institute of Allergy and Infectious Diseases (U.S.)
18%
Therapeutics
17%
Tachypnea
15%
Hospitalized Child
14%
Hemagglutination
13%
Antibodies
13%
Adult Respiratory Distress Syndrome
13%
Respiratory Rate
12%
National Institutes of Health (U.S.)
12%
Artificial Respiration
11%
Pregnant Women
9%
Air
9%
Hypoxia
9%
Oxygen
8%
Stroke
8%
Pediatrics
7%
Polymerase Chain Reaction
7%
Morbidity
7%
Safety
7%
Mortality
6%
Child
5%